22 May 2013
Keywords: analysts, discuss, impact, troglitazone, meeting, march, after
Article | 29 March 1999
On March 26, after this issue of Marketletter goes to press,Warner-Lambert's type 2 diabetes treatment Rezulin (troglitazone) was
due to be ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
29 March 1999
21 May 2013
© 2013 thepharmaletter.com